DGCI approves for phase III trial of Bharat Biotech intranasal vaccine as booster

New Delhi, Jan 5 (IANS) The Subject Experts Committee (SEC) of the Drug Controller General of India (DGCI) on Wednesday granted "in principle" approval to Bharat Biotech to conduct "Phase III superio...

Become a proud member of 1947.com to access this content.